Included on a global watchlist of large-cap pharma companies to track the sector, with no specific buy or sell thesis mentioned.

Faces a significant reputational risk as its well-known brand, Valium, is being counterfeited and associated with overdose deaths, potentially leading to stricter regulatory controls.